NCT03549234View on ClinicalTrials.gov

Erector Spinae Versus Paravertebral Nerve Blocks for Breast Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 12, 2018

Primary Completion Date

May 8, 2019

Study Completion Date

May 8, 2019

Conditions
Breast Surgery
Interventions
DRUG

Erector Spinae (single injection)

Ropivacaine 0.5% (with epinephrine 1:200,000-400,000) will be administered via the needle into the target plane.

DRUG

Paravertebral (single injection)

Ropivacaine 0.5% (with epinephrine 1:200,000-400,000) will be administered via the needle into the target plane.

Trial Locations (1)

92103

UCSD Medical Center (Hillcrest and Thornton), San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT03549234 - Erector Spinae Versus Paravertebral Nerve Blocks for Breast Surgery | Biotech Hunter | Biotech Hunter